generic

Latest stories

  • in Health care

    Decoding Safety and Efficacy of Generic Tofacitinib Tablets in Rheumatoid Arthritis: Indian Evidence

    Decoding Safety and Efficacy of Generic Tofacitinib Tablets in Rheumatoid Arthritis: Indian Evidence

    by

    Rheumatoid Arthritis (RA) is one of the most debilitating chronic autoimmune affecting joints leading to inflammation, pain, persistent synovitis, and eventual joint destruction. RA primarily affects small joints and may have extra-articular involvement in organs such as the lungs, heart etc. Prima facie, this disease causes severe disability, decreased quality of life and life expectancy. […] More

  • in Health care

    FDA withdraws preterm birth drug Makena (hydroxyprogesterone) and its generic versions

    FDA withdraws preterm birth drug Makena (hydroxyprogesterone) and its generic versions

    by

    USA: Noting that the drug was ineffective in treating the complication of preterm birth, the US Food and Drug Administration (FDA), in its recent announcement, has decided to withdraw approval of Makena, hydroxyprogesterone caproate injection, and its generic versions. The decision was issued jointly by the FDA Commissioner and Chief Scientist. FDA stated, “Effective from […] More

  • in Health care

    Torrent Pharma unveils generic version of Keveyis tablets in US

    Torrent Pharma unveils generic version of Keveyis tablets in US

    by

    Basking Ridge: Torrent Pharma has begun shipping the generic version of Xeris’s Keveyis (dichlorphenamide), 50mg tablets, following final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application. Torrent is distributing the product through select specialty pharmacies beginning this month. Dichlorphenamide Tablets are indicated for the treatment of primary hyperkalemic periodic […] More

  • in Health care

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    by

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More